The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESSO 43 | Evolving colorectal cancer treatment: combining chemo, radiotherapy, and advanced robotic surgery
Richard Hillegersberg, MD, PhD, UMC Utrecht, Utrecht, Netherlands, discusses the evolving treatment approach for colorectal cancer, highlighting the shift from traditional surgery to a combination of chemotherapy, radiotherapy, and advanced robotic surgery. He explains that robotic techniques have made complex surgeries, including those for advanced-stage cancers, more precise and minimally invasive, with the robot providing enhanced imaging and control for oncological dissections. This interview took place at the ESSO 43 congress in Antwerp, Belgium.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
